Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial

Nutrition and Metabolism

Volumn 8, Issue , 2011, Pages

  Schmidt, Melanie ^a   Pfetzer, Nadja ^a   Schwab, Micheal ^a   Strauss, Ingrid ^a   Kämmerer, Ulrike ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

cancer patients; Ketogenic diet; pilot study; quality of life

Indexed keywords

CHOLESTEROL; CISPLATIN; FAT; FLUOROURACIL; FOOD ADDITIVE; HIGH DENSITY LIPOPROTEIN; KETONE BODY; LOW DENSITY LIPOPROTEIN; PROTEIN; TRIACYLGLYCEROL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASCITES; CANCER MORTALITY; CHEMOTHERAPY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONSTIPATION; EMOTION; ESOPHAGUS CARCINOMA; FATIGUE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FOOD INTAKE; HUMAN; INSOMNIA; KETOGENIC DIET; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLISM; MULTIPLE CYCLE TREATMENT; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR GROWTH; URINE LEVEL; WEAKNESS; WEIGHT REDUCTION;

EID: 79960688044     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-8-54     Document Type: Article

References (56)

1. Versuche am überlebenden Carzinom-Gewebe. Warburg O, Minami S, Klin Wochenschr 1923 2 776 777 10.1007/BF01712130
2. On the origin of cancer cells. Warburg O, Science 1956 123 309 314 10.1126/science.123.3191.309 13298683
3. Energy metabolism in tumor cells. Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E, FEBS J 2007 274 1393 1418 10.1111/j.1742-4658.2007.05686.x 17302740 (Pubitemid 46333738)
4. Brick by brick: metabolism and tumor cell growth. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB, Curr Opin Genet Dev 2008 18 54 61 10.1016/j.gde.2008.02.003 18387799 (Pubitemid 351694453)
5. Glycolysis inhibition for anticancer treatment. Pelicano H, Martin DS, Xu RH, Huang P, Oncogene 2006 25 4633 4646 10.1038/sj.onc.1209597 16892078 (Pubitemid 44187614)
6. The Warburg effect and its cancer therapeutic implications. Chen Z, Lu W, Garcia-Prieto C, Huang P, J Bioenerg Biomembr 2001 39 267 274
7. Targeting of cancer energy metabolism. Rodríguez-Enríquez S, Marín-Hernández A, Gallardo-Pérez JC, Carrẽo-Fuentes L, Moreno-Sánchez R, Mol Nutr Food Res 2009 53 29 48 10.1002/mnfr.200700470 19123180
8. Zur Diagnose des Carzinoms. Vorläufige Mittheilung. Freund E, Wien Med Bl 1885 8 267
9. ber die Beziehung des Geschwulstwachstums zur Ernährung und zum Stoffwechsel. II. Mitteilung. Versuche zur Frage der Bedeutung der Kohlenhydrate für das Wachstum des Rattencarzinoms. Händel M, Tadenuma K, Z Krebsforsch (J Cancer Res and Clin Oncol) 1924 21 288 293
10. The glucose metabolism of patients with malignant disease and of normal subjects as studied by means of an intravenous glucose tolerance test. Marks PA, Bishop JS, J Clin Invest 1957 36 254 264 10.1172/JCI103419 13406036
11. Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects. Zuijdgeest-van Leeuwen SD, van den Berg JW, Wattimena JL, van der Gaast A, Swart GR, Wilson JH, Dagnelie PC, Metabolism 2000 49 931 6 10.1053/meta.2000.6740 10910006 (Pubitemid 30483448)
12. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Buzzai M, Bauer DE, Jones RG, Deberardinis RJ, Hatzivassiliou G, Elstrom RL, Thompson CB, Oncogene 2005 24 4165 4173 10.1038/sj.onc.1208622 15806154 (Pubitemid 40961771)
13. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN, Nutr Metab (Lond) 2007 4 5 10.1186/1743-7075-4-5 (Pubitemid 46393945)
14. Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Fine EJ, Miller A, Quadros EV, Sequeira JM, Feinman RD, Cancer Cell Int 2009 29 14
15. Ketone bodies inhibit the viability of human neuroblastoma cells. Skinner R, Trujillo A, Ma X, Beierle EA, J Pediatr Surg 2009 44 212 6 10.1016/j.jpedsurg.2008.10.042 19159745
16. Substrate balances across colonic carcinomas in humans. Holm E, Hagmüller E, Staedt U, Schlickeiser G, Günther HJ, Leweling H, Tokus M, Kollmar HB, Cancer Res 1995 55 1373 8 7882338
17. The Effects on Human Beings of a Twelve Months' Exclusive Meat Diet. Lieb CW, JAMA 1929 93 20 22
18. The effect of ketonemia on the course of epilepsy. Wilder RM, Mayo Clin Bulletin 1921 2 307 308
19. More fat and fewer seizure: diatary therapies for epilepsy. Kosoff EH, Lancet Neurol 2004 3 415 420 10.1016/S1474-4422(04)00807-5 15207798 (Pubitemid 38789137)
20. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A, Cross JH, Lancet Neurol 2008 7 500 506 10.1016/S1474-4422(08)70092-9 18456557
21. From observations to trials: the ketogenic diet and epilepsy. Wiznitzer M, Lancet Neurol 2008 7 471 472 10.1016/S1474-4422(08)70093-0 18456560
22. Atkins RC, Dr. Atkins' diet revolution. The high calorie way to stay thin forever D. McKay Co, New York 1972 21530411
23. Kirby RK, 2005 http://www.aafp.org/online/en/home/clinical/publichealth/ nutrition/atkinsdiet.html
24. A low-carbohydrate as compared with a low-fat diet in severe obesity. Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams T, Williams M, Gracely EJ, Stern L, N Engl J Med 2003 348 2074 2081 10.1056/NEJMoa022637 12761364 (Pubitemid 36583302)
25. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Blüher M, Stumvoll M, Stampfer MJ, Intervention Randomized Controlled Trial (DIRECT) Group, N Engl J Med 2008 359 229 241 10.1056/NEJMoa0708681 18635428 (Pubitemid 352008438)
26. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. Nebeling LC, Miraldi F, Shurin SB, Lerner E, J Am Coll Nutr 1995 14 202 208 7790697
27. ber den Einflu verschiedener Ernährung auf Tumorempfänglichkeit und Tumorwachstum bei Mäusen. Freund E, Z Krebsforsch (J Cancer Res and Clin Oncol) 1932 37 354 361
28. ber den Einflu der Kost auf das Wachstum von Impfgeschwüren. VI. Mitteilung. ber den Einflu des Palmitins auf das Geschwulstwachstum. Caspari W, Z Krebsforsch (J Cancer Res and Clin Oncol) 1933 38 355 360
29. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report. Zuccoli G, Marcello N, Pisanello A, Servadei F, Vaccaro S, Mukherjee P, Seyfried TN, Nutr Metab (Lond) 2010 22 33
30. The inhibition of malignant cell growth by ketone bodies. Magee BA, Potezny N, Rofe AM, Conyers RA, Aust J Exp Biol Med Sci 1979 57 529 539 10.1038/icb.1979.54 548019 (Pubitemid 10068011)
31. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Freedland SJ, Mavropoulos J, Wang A, Darshan M, Demark-Wahnefried W, Aronson WJ, Cohen P, Hwang D, Peterson B, Fields T, Pizzo SV, Isaacs WB, Prostate 2008 68 11 19 10.1002/pros.20683 17999389
32. Dietary canola oil suppressed growth of implanted MDA-MB 231 human breast tumors in nude mice. Hardman WE, Nutr Cancer 2007 57 177 183 10.1080/01635580701277445 17571951 (Pubitemid 47080090)
33. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. Otto C, Kaemmerer U, Illert B, Muehling B, Pfetzer N, Wittig R, Voelker HU, Thiede A, Coy JF, BMC Cancer 2008 30 122
34. The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osboa D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F, J Natl Cancer Inst 1993 85 365 376 10.1093/jnci/85.5.365 8433390 (Pubitemid 23073154)
35. Karnofsky performance status revisited: reliability, validity, and guidelines. Schag CC, Heinrich RL, Ganz PA, J Clin Oncol 1984 2 187 93 6699671 (Pubitemid 14138407)
36. Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy: a randomized controlled study. Breitkreutz R, Tesdal K, Jentschura D, Haas O, Leweling H, Holm E, Wien Klin Wochenschr 2005 117 685 692 10.1007/s00508-005-0455-3 16416368 (Pubitemid 41719684)
37. Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP, Am J Clin Oncol 1982 5 649 655 10.1097/00000421-198212000-00014 7165009 (Pubitemid 13149996)
38. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, EORTC Quality of Life Group, 2001
39. A simple sequentially rejective multiple test procedure. Holm S, Scand J Statistics 1979 6 65 70
40. Ketogenic diet treatment in adults with refractory epilepsy: A prospective pilot study. Mosek A, Natour H, Neufeld MY, Shiff Y, Vaisman N, Seizure 2007 18 30 33
41. Diet, exercise, and complementary therapies after primary treatment for cancer. Jones LW, Demark-Wahnefried W, Lancet Oncol 2006 7 1017 26 10.1016/S1470-2045(06)70976-7 17138223 (Pubitemid 44804143)
42. The role of complementary and alternative medicine in cancer. Ernst E, Lancet Oncol 2000 1 176 80 10.1016/S1470-2045(00)00031-0 11905656
43. Low-carb diets, fasting and euphoria: Is there a link between ketosis and gamma-hydroxybutyrate (GHB)? Brown AJ, Med Hypotheses 2007 68 268 271 10.1016/j.mehy.2006.07.043 17011713 (Pubitemid 44879832)
44. Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant? Nuttall FQ, Ngo A, Gannon MC, Diabetes Metab Res Rev 2008 24 438 458 10.1002/dmrr.863 18561209
45. Altered glucose metabolism in metastatic carcinoma. Holroyde CP, Gabuzda TG, Putnam RC, Paul P, Reichard GA, Cancer Res 1975 35 3710 3714 1192429
46. Beliveau R, Gingras D, Krebszellen mögen keine Himberen (Les aliments contre le cancer) München: Kösel-Verlag 2008
47. Comparison of capillary blood ketone measurement by electrochemical method and urinary ketone in treatment of diabetic ketosis and ketoacidosis in children. Turan S, Omar A, Bereket A, Acta Diabeto 2008 45 83 5 10.1007/s00592-008-0026-y
48. Low-carbohydrate diets: nutritional and physiological aspects. Adam-Perrot A, Clifton P, Brouns F, Obes Rev 2006 7 49 58 10.1111/j.1467-789X. 2006.00222.x 16436102
49. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR, Kraemer HC, King AC, JAMA 2007 297 969 977 10.1001/jama.297.9.969 17341711 (Pubitemid 46376751)
50. Multi-targeted therapy of cancer by omega-3 fatty acids. Berquin IM, Edwards IJ, Chen YQ, Cancer Lett 2008 269 363 377 10.1016/j.canlet.2008.03.044 18479809
51. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Colomer R, Moreno-Nogueira JM, García-Luna PP, García-Peris P, García-de-Lorenzo A, Zarazaga A, Quecedo L, del Llano J, Usán L, Casimiro C, Br J Nutr 2007 97 823 831 10.1017/S000711450765795X 17408522 (Pubitemid 46554396)
52. (n-3) fatty acids and cancer therapy. Hardman WE, J Nutr 2004 134 12 Suppl 3427S 3430S 15570049 (Pubitemid 39587585)
53. Dietary omega-3-polyunsaturated fatty acids prevent the development of metastases of colon carcinoma in rat liver. Gutt CN, Brinkmann L, Mehrabi A, Fonouni H, Müller-Stich BP, Vetter G, Stein JM, Schemmer P, Büchler MW, Eur J Nutr 2007 46 279 285 10.1007/s00394-007-0662-y 17593466 (Pubitemid 47125268)
54. Cancer cachexia: influence of systemic ketosis on substrate levels and nitrogen metabolism. Fearon KC, Borland W, Preston T, Tisdale MJ, Shenkin A, Calman KC, Am J Clin Nutr 1988 47 42 48 3122552 (Pubitemid 18091537)
55. Carbohydrate restriction in patients with advanced cancer: a protocol to assess safety and feasibility with an accompanying hypothesis. Fine EJ, Segal-Isaacson CJ, Feinman R, Sparano J, Commun Oncol 2008 5 22 26 (Pubitemid 351212033)
56. Clinical trials homepage http://clinicaltrials.gov registration numbers: NCT00575146, NCT00444054, NCT00932672, NCT01092247